HR+ breast tumors regardless of HER2 status (HR+/HER2+ and HR+/HER2−) were more likely to harbor CNAs in CCND1, FGF3, FGF4, and FGF19, which colocalizes in chromosome 11q13.3. The gene discussed is FGF19; the disease is breast neoplasm.